TE
ELVN icon

Tema ETFs’s Enliven Therapeutics ELVN Stock Holding History

Tema ETFs’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Buy
60,694
+17,638
+41% +$749K 0.1% 146
2026
Q1 		$1.69M Buy
+43,056
New +$1.19M 0.11% 165
2025
Q4 		– Sell
-40,314
Closed -$825K – 575
2025
Q3 		$825K Buy
40,314
+7,735
+24% +$156K 0.07% 291
2025
Q2 		$654K Buy
32,579
+8,931
+38% +$169K 0.17% 123
2025
Q1 		$465K Buy
+23,648
New +$509K 0.14% 114

Other funds holding ELVN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
FIA
FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return